Tectonic Therapeutics TECX Foreign currency translation gains (losses)
Foreign currency translation gains (losses) at other companies
Other financials
Where this comes from
Reported directly by Tectonic Therapeutics in its filing.
Tagged under the XBRL concept us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax.
The official record: Tectonic Therapeutics’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about Tectonic Therapeutics's foreign currency translation gains (losses).
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Tectonic Therapeutics's foreign currency translation gains (losses)?
- Tectonic Therapeutics (TECX) reported foreign currency translation gains (losses) of $37K in Q1 2026.
- How has Tectonic Therapeutics's foreign currency translation gains (losses) changed year-over-year?
- Tectonic Therapeutics's foreign currency translation gains (losses) increased by 628.6% year-over-year, from -$7K to $37K.
- What is the long-term trend for Tectonic Therapeutics's foreign currency translation gains (losses)?
- Over 2 years (2023 to 2025), Tectonic Therapeutics's foreign currency translation gains (losses) has grown at a 209.0% compound annual growth rate (CAGR), from -$11K to -$105K.
- What does foreign currency translation gains (losses) mean?
- This metric captures the net gains or losses resulting from the translation of financial statements from foreign functional currencies into the company's reporting currency. It reflects the impact of exchange rate fluctuations on the value of international assets, liabilities, and equity over the reporting period. This figure is essential for assessing the company's exposure to currency risk and the volatility of its international operations.